Stress ulcer prevention--the controversy continues.
A recently published meta-analysis has re-awakened the controversy regarding the risk and benefits of using acid-suppressant drugs to prevent stress ulceration in intensive care patients.
Bradley
C
C
Prinicipal Pharmacist Clinical Support, St. George's Hospital, London, UK.
D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007362:Intensive Care Units; D010437:Peptic Ulcer / Q000209:etiology* / Q000517:prevention & control*; D011899:Ranitidine / Q000627:therapeutic use; D013315:Stress, Psychological / Q000150:complications*; D013392:Sucralfate / Q000627:therapeutic use
D000863:Antacids; D000897:Anti-Ulcer Agents; D013392:Sucralfate; D011899:Ranitidine